These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15351948)

  • 21. Disorders of steroid 11 beta-hydroxylase isozymes.
    White PC; Curnow KM; Pascoe L
    Endocr Rev; 1994 Aug; 15(4):421-38. PubMed ID: 7988480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial varieties of primary aldosteronism.
    Stowasser M; Gunasekera TG; Gordon RD
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1087-90. PubMed ID: 11903322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.
    Carvajal CA; Stehr CB; González PA; Riquelme EM; Montero T; Santos MJ; Kalergis AM; Fardella CE
    J Endocrinol Invest; 2011 Feb; 34(2):140-4. PubMed ID: 20634641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
    Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
    Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of patients for surgery for primary aldosteronism.
    Plouin PF; Rossignol P; Amar L
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):522-5. PubMed ID: 18307754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal salt-wasting and 11 beta-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 beta-hydroxylase).
    Ezquieta B; Luzuriaga C
    Clin Genet; 2004 Sep; 66(3):229-35. PubMed ID: 15324322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alterations in patients with primary aldosteronism.
    Takeda Y
    Hypertens Res; 2001 Sep; 24(5):469-74. PubMed ID: 11675938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.
    Aglony M; Martínez-Aguayo A; Carvajal CA; Campino C; García H; Bancalari R; Bolte L; Avalos C; Loureiro C; Trejo P; Brinkmann K; Giadrosich V; Mericq V; Rocha A; Avila A; Perez V; Inostroza A; Fardella CE
    Hypertension; 2011 Jun; 57(6):1117-21. PubMed ID: 21502562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hyperaldosteronism.
    Stowasser M; Gordon RD
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
    Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
    J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
    Zennaro MC; Jeunemaitre X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone-suppressible hyperaldosteronism: clinical, biochemical and genetic relations.
    Connell JM; Inglis GC; Fraser R; Jamieson A
    J Hum Hypertens; 1995 Jun; 9(6):505-9. PubMed ID: 7473536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma.
    Tunny TJ; Jonsson JR; Klemm SA; Ballantine DM; Stowasser M; Gordon RD
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1312-7. PubMed ID: 7980610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.
    Takeda Y; Furukawa K; Inaba S; Miyamori I; Mabuchi H
    J Clin Endocrinol Metab; 1999 May; 84(5):1633-7. PubMed ID: 10323392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
    Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
    Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
    Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.
    So A; Duffy DL; Gordon RD; Jeske YW; Lin-Su K; New MI; Stowasser M
    J Hypertens; 2005 Aug; 23(8):1477-84. PubMed ID: 16003173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.
    Lenzini L; Caroccia B; Campos AG; Fassina A; Belloni AS; Seccia TM; Kuppusamy M; Ferraro S; Skander G; Bader M; Rainey WE; Rossi GP
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E674-82. PubMed ID: 24285684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.